EPS for Sientra, Inc. (SIEN) Expected At $-0.71

February 23, 2018 - By Kurt Siggers

 EPS for Sientra, Inc. (SIEN) Expected At $ 0.71
Investors sentiment decreased to 1.52 in 2017 Q3. Its down 0.34, from 1.86 in 2017Q2. It dropped, as 9 investors sold Sientra, Inc. shares while 14 reduced holdings. 13 funds opened positions while 22 raised stakes. 14.36 million shares or 1.78% more from 14.11 million shares in 2017Q2 were reported.
Barclays Public Ltd Com, a United Kingdom-based fund reported 10,132 shares. New York-based Pura Vida Lc has invested 1.45% in Sientra, Inc. (NASDAQ:SIEN). Bamco Inc Ny reported 501,500 shares. State Common Retirement Fund owns 15,200 shares. Weiss Multi invested 0.01% of its portfolio in Sientra, Inc. (NASDAQ:SIEN). Thompson Davis And Com stated it has 0.01% in Sientra, Inc. (NASDAQ:SIEN). Accredited Investors Incorporated owns 11,826 shares. Tower Research Capital Limited Liability Corporation (Trc) holds 0% or 2,339 shares. 282,500 are owned by Bridgeway Cap Mngmt. Bankshares Of Montreal Can reported 0% of its portfolio in Sientra, Inc. (NASDAQ:SIEN). Wells Fargo And Comm Mn holds 22,903 shares. Legal & General Public Ltd holds 0% or 3,031 shares. State Bank Of Mellon Corp stated it has 88,009 shares. Strs Ohio, Ohio-based fund reported 3,800 shares. Vanguard Inc owns 609,620 shares for 0% of their portfolio.

Analysts expect Sientra, Inc. (NASDAQ:SIEN) to report $-0.71 EPS on March, 13.They anticipate $0.28 EPS change or 65.12 % from last quarter’s $-0.43 EPS. After having $-0.74 EPS previously, Sientra, Inc.’s analysts see -4.05 % EPS growth. The stock decreased 2.11% or $0.2 during the last trading session, reaching $9.29. About 577,226 shares traded or 124.52% up from the average. Sientra, Inc. (NASDAQ:SIEN) has risen 27.61% since February 23, 2017 and is uptrending. It has outperformed by 10.91% the S&P500.

Sientra, Inc. (NASDAQ:SIEN) Ratings Coverage

Among 5 analysts covering Sientra (NASDAQ:SIEN), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Sientra had 12 analyst reports since August 14, 2015 according to SRatingsIntel. Canaccord Genuity maintained Sientra, Inc. (NASDAQ:SIEN) rating on Thursday, January 4. Canaccord Genuity has “Buy” rating and $19.0 target. The firm earned “Hold” rating on Tuesday, September 26 by Stifel Nicolaus. The firm has “Outperform” rating given on Wednesday, September 13 by William Blair. The stock of Sientra, Inc. (NASDAQ:SIEN) has “Market Perform” rating given on Wednesday, August 10 by William Blair. The rating was upgraded by Stifel Nicolaus on Friday, January 19 to “Buy”. The rating was maintained by Canaccord Genuity with “Buy” on Tuesday, October 17. The stock has “Hold” rating by Stifel Nicolaus on Thursday, February 11. Stifel Nicolaus maintained the shares of SIEN in report on Wednesday, August 9 with “Hold” rating. Canaccord Genuity initiated Sientra, Inc. (NASDAQ:SIEN) rating on Monday, August 28. Canaccord Genuity has “Buy” rating and $14.0 target. The rating was maintained by Canaccord Genuity with “Buy” on Sunday, October 8.

Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. The company has market cap of $180.25 million. The firm offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; and breast tissue expanders. It currently has negative earnings. It also provides body contouring products; facial and nasal implants; scar management products under the bioCorneum and Silishield brand names; saline-filled breast implant sizers to identify the correct style and size of implants; and non-breast tissue expanders for expanding tissue and skin surface area for burn care and other reconstructive use.

More important recent Sientra, Inc. (NASDAQ:SIEN) news were published by: Globenewswire.com which released: “Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)” on January 25, 2018, also Globenewswire.com published article titled: “Sientra® Provides Update on FDA Review of US Manufacturing Facility”, Globenewswire.com published: “Sientra Launches New miraDry freshâ„¢ Protocol for the miraDry® System at …” on February 16, 2018. More interesting news about Sientra, Inc. (NASDAQ:SIEN) was released by: Globenewswire.com and their article: “Lubrizol Customer, Sientra, Inc., Receives FDA Approval to Manufacture Breast …” with publication date: February 06, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.